How can the personal discovery process evolve personalized medicine? An interview with Laura Towart.
Abstract
Laura is the Founder and CEO of My Personal Therapeutics, a London-based digital health company offering the most advanced personalized cancer therapeutics. She is also the Founder and former CEO of Celmatix, a leader in diagnostics and predictive analytics for female infertility and women's health. She is a graduate of the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan Kettering Cancer Center's Doctoral program and received a Certificate in Bioinformatics. She holds a BS/BA in Biology/English from The George Washington University. Besides being passionate about personalized medicine, she enjoys exploring the world with her children Julian, Valentina and Delphine.
Keywords
Access
Citation
ID:
44845
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
44845
Unique Identifier:
10.2217/pme-2019-0087
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
